Diaphragmatic Echography in COVID-19 Pneumonia

NCT05805579 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 171

Last updated 2023-04-10

No results posted yet for this study

Summary

We hypothesized that diaphragm thickness is concerned in acute respiratory failure of COVID19 patients and its ultrasound measure at the begining of hospitalisation is a good predictor of poor outcome.

A prospective observational non intervention study is designed.

Conditions

Interventions

DIAGNOSTIC_TEST

Diaphragmatic echography

Diaphragmatic echography

Sponsors & Collaborators

  • Sociedad Aragonesa de Patología del Aparato Respiratorio

    collaborator UNKNOWN
  • Javier Lázaro

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-06-20
Completion
2021-06-20

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05805579 on ClinicalTrials.gov